Half-dose fingolimod for treating relapsing-remitting multiple sclerosis: Observational study.
Zecca C, Merlini A, Disanto G, Rodegher M, Panicari L, Romeo MAL, Candrian U, Messina MJ, Pravatà E, Moiola L, Stefanin C, Ghezzi A, Perrone P, Patti F, Comi G, Gobbi C, Martinelli V.
Zecca C, et al. Among authors: comi g.
Mult Scler. 2018 Feb;24(2):167-174. doi: 10.1177/1352458517694089. Epub 2017 Feb 1.
Mult Scler. 2018.
PMID: 28273776